BRPI0212586B8 - composição na forma de uma solução aquosa, e, uso da mesma - Google Patents

composição na forma de uma solução aquosa, e, uso da mesma

Info

Publication number
BRPI0212586B8
BRPI0212586B8 BRPI0212586A BR0212586A BRPI0212586B8 BR PI0212586 B8 BRPI0212586 B8 BR PI0212586B8 BR PI0212586 A BRPI0212586 A BR PI0212586A BR 0212586 A BR0212586 A BR 0212586A BR PI0212586 B8 BRPI0212586 B8 BR PI0212586B8
Authority
BR
Brazil
Prior art keywords
salt
combination
ipratropium
composition
xylometazoline
Prior art date
Application number
BRPI0212586A
Other languages
English (en)
Portuguese (pt)
Other versions
BR0212586B1 (pt
BR0212586A (pt
Inventor
Anette Moesgaard Hanne
Lowenstein Christensen Karin
Original Assignee
Nycomed Danmark Aps
Takeda Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps, Takeda Pharma As filed Critical Nycomed Danmark Aps
Publication of BR0212586A publication Critical patent/BR0212586A/pt
Publication of BR0212586B1 publication Critical patent/BR0212586B1/pt
Publication of BRPI0212586B8 publication Critical patent/BRPI0212586B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
BRPI0212586A 2001-09-18 2002-09-18 composição na forma de uma solução aquosa, e, uso da mesma BRPI0212586B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (3)

Publication Number Publication Date
BR0212586A BR0212586A (pt) 2004-10-13
BR0212586B1 BR0212586B1 (pt) 2013-11-19
BRPI0212586B8 true BRPI0212586B8 (pt) 2021-05-25

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0212586A BRPI0212586B8 (pt) 2001-09-18 2002-09-18 composição na forma de uma solução aquosa, e, uso da mesma

Country Status (20)

Country Link
US (2) US7652030B2 (https=)
EP (2) EP1446119B1 (https=)
JP (1) JP4500045B2 (https=)
KR (1) KR100810872B1 (https=)
CN (1) CN1290502C (https=)
AT (1) ATE318601T1 (https=)
BR (1) BRPI0212586B8 (https=)
CA (1) CA2460140C (https=)
DE (1) DE60209511T2 (https=)
DK (1) DK1446119T3 (https=)
EA (1) EA008165B1 (https=)
ES (1) ES2259098T3 (https=)
HU (1) HU226527B1 (https=)
MX (1) MXPA04002500A (https=)
NO (1) NO334441B1 (https=)
NZ (1) NZ531792A (https=)
PL (1) PL208686B1 (https=)
PT (1) PT1446119E (https=)
SI (1) SI1446119T1 (https=)
WO (1) WO2003024433A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
HU226527B1 (hu) * 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
RU2006132043A (ru) * 2004-02-06 2008-03-20 МЕДА Фарма ГмбХ унд Ко.КГ (DE) Комбинация и фармацевтический препарат для лечения ринита
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
EA035261B1 (ru) 2014-05-07 2020-05-21 Бёрингер Ингельхайм Интернациональ Гмбх Небулайзер и контейнер
PL3236933T3 (pl) * 2014-12-24 2019-05-31 Jadran Galenski Laboratorij D D Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość
MX383771B (es) * 2015-12-02 2025-03-14 Pablo Cortes Borrego Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122719A1 (en) * 1991-11-19 1993-05-27 Jack M. Gwaltney, Jr. Combined virustatic antimediator (covam) treatment of common colds
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
SK280911B6 (sk) * 1992-12-09 2000-09-12 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostriedok
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JP2001524108A (ja) 1997-04-30 2001-11-27 ワーナー−ランバート・カンパニー 局所経鼻抗炎症組成物
DK1051155T3 (da) * 1998-01-30 2002-09-16 Novartis Consumer Health Sa Nasale opløsninger
CN1161104C (zh) 1998-06-18 2004-08-11 贝林格尔·英格海姆药物公司 有二种或多种活性物质的气溶胶药物制剂
TR200103694T2 (tr) 1999-06-22 2002-04-22 Boehringer Ingelheim International Gmbh Sabit ksilometazolin ve oksimetazolin çözeltisi
HU226527B1 (hu) * 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére

Also Published As

Publication number Publication date
EP1661570A3 (en) 2012-10-24
EP1446119B1 (en) 2006-03-01
JP2005505569A (ja) 2005-02-24
WO2003024433A2 (en) 2003-03-27
EP1446119A2 (en) 2004-08-18
MXPA04002500A (es) 2004-11-22
KR20040049849A (ko) 2004-06-12
US20100093783A1 (en) 2010-04-15
JP4500045B2 (ja) 2010-07-14
HK1067984A1 (en) 2005-04-22
BR0212586B1 (pt) 2013-11-19
EP1661570A2 (en) 2006-05-31
DE60209511T2 (de) 2006-10-05
SI1446119T1 (sl) 2006-08-31
KR100810872B1 (ko) 2008-03-06
PL370536A1 (en) 2005-05-30
NZ531792A (en) 2006-02-24
NO334441B1 (no) 2014-03-03
US20040248924A1 (en) 2004-12-09
ES2259098T3 (es) 2006-09-16
US8450339B2 (en) 2013-05-28
EA008165B1 (ru) 2007-04-27
CA2460140C (en) 2009-09-01
DK1446119T3 (da) 2006-07-10
HUP0402075A2 (hu) 2005-02-28
CA2460140A1 (en) 2003-03-27
CN1290502C (zh) 2006-12-20
DE60209511D1 (de) 2006-04-27
HUP0402075A3 (en) 2008-04-28
PT1446119E (pt) 2006-07-31
EA200400444A1 (ru) 2005-02-24
HU226527B1 (hu) 2009-03-30
BR0212586A (pt) 2004-10-13
PL208686B1 (pl) 2011-05-31
CN1555263A (zh) 2004-12-15
US7652030B2 (en) 2010-01-26
WO2003024433A3 (en) 2004-06-10
ATE318601T1 (de) 2006-03-15
NO20041070L (no) 2004-05-18

Similar Documents

Publication Publication Date Title
BRPI0212586B8 (pt) composição na forma de uma solução aquosa, e, uso da mesma
BR0207420A (pt) Processo e composições para desinfecção de superfìcies duras
BR0211284A (pt) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, a respectiva preparação e a respectiva aplicação em terapêutica
BR0116605A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BR0109966A (pt) Combinação de compostos orgânicos
BR0116266A (pt) Derivados de quinazolina, composições farmacêuticas contendo estes compostos, seu uso e processos para sua preparação
BR0116201A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende o composto, utilização do composto, processo para o tratamento e profilaxia de distúrbios e para o tratamento de obesidade
BR0314353A (pt) Compostos, composições farmacêuticas, uso de um ou mais compostos em combinação com outros compostos farmacologicamente ativos, e, método para tratar um paciente que sofre de um distúrbio
BRPI0109131B8 (pt) dna, vetor de expressão compreendendo o mesmo, fator viii modificado de porcino, seu processo de produção e composição terapêutica compreendendo o mesmo
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
BR0308902A (pt) 4-(n-fenilamino)-quinazolinas/quinolinas como inibidoras da tirosina cinase
BR9807876A (pt) Compostos heterocìclicos e seu uso para inibição de peptìdeo beta-amilóide
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
BR0212787A (pt) Composto ou sal farmaceuticamente aceitável do mesmo, métodos de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto ou sal, e, composição farmacêutica
BR0211118A (pt) Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal
BRPI0407709A (pt) heterociclos bicìclicos, composições farmacêuticas contendo esses compostos, seu uso e processos para o preparo dos mesmos
BR9807950A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto
BRPI0518231A2 (pt) derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica
BR9914266A (pt) Derivados de propanolamina substituìdos por heterociclos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego
BR112022023506A2 (pt) Composto, composição farmacêutica, uso do composto e método de uso de um composto
BR0208353A (pt) Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças
BRPI0409884A (pt) compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/137, 31/415, 31/4164, 31/46, 31/4745, 47/02, 47/04, 47/10, 47/12, 47/16, 47/"18, 47/32, 47/36, 47/38, 9/08, 9/12

Ipc: A61K 31/137 (2011.01), A61K 31/415 (2011.01), A61K

Free format text: PARA: INT. CL. A61K 31/137, 31/415, 31/4164, 31/46, 31/4745, 47/02, 47/04, 47/10, 47/12, 47/16, 47/18, 47/32, 47/36, 47/38, 9/08, 9/12; A61P 11/00; A61P 11/02

Ipc: A61K 31/137 (2011.01), A61K 31/415 (2011.01), A61K

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/11/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/09/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 18/09/2022